Title: Design, synthesis, structure--selectivity relationship, and effect on human cancer cells of a novel series of histone deacetylase 6-selective inhibitors.
Journal: Journal of medicinal chemistry 20071101
610273-01-3 | L-Asparagine,L-isoleucyl-L-leucyl-L-lysyl-L-glutaminyl-L-seryl-L-methionyl-L-threonyl-L-leucyl-L-asparaginyl-L-leucyl-L-alanyl-L-a-aspartyl-L-prolyl-L-valylglycyl-L-seryl-L-leucyl-L-lysyl-L-prolyl-L-histidyl-L-leucyl-L-arginyl-L-alanyl-L-lysyl- | AA01ENNI | MFCD06798316
877636-42-5 | Ml221 | AA01ENWR | MFCD06407006
168635-85-6 | Carcinoembryonic Antigen CEA | AA01EO1P | MFCD06657932
1022899-36-0 | PCI-33380 | AA01EO5N | MFCD30533364
1617495-03-0 | RA190 | AA01EOB7 | MFCD30738021
2215120-36-6 | Interferon receptor agonist | AA01EOHB | MFCD31746883
5081-48-1 | Ellipticine hydrochloride | AA01EOMK | MFCD00050600
26771-95-9 | 9β,11α,15S-trihydroxy-(8β)-prost-13E-en-1-oicacid | AA01EOR2
1843184-42-8 | 1-(5-fluoro-4-hydroxypentyl)-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indazole-3-carboxamide | AA01EP19 | MFCD29036749
1381846-21-4 | 2-chloro-5-[[(2,2-dimethyl-1-oxopropyl)amino]methyl]-N-1H-imidazol-2-yl-benzamide | AA01EPC0 | MFCD25976583